Salah Al-Din – Conscious – Falih Al-Obaidi
The General Company for the Manufacture of Pharmaceuticals and Medical Supplies in Samarra announced today, Friday, the resumption of production of Panadosam, while setting the date for its marketing in local markets..
The general director of the company, Muhammad Abdul Qadir Al-Nuaimi, told the (INA): “The General Company for Pharmaceutical Manufacturing has begun producing Panadosam syrup (suspension) within its production program for the current month of November after a pause that lasted for more than two years,” indicating that “it has been stopped.” The production of the readiness came about due to a shortage of some of the raw materials involved in its production“.
He added, “The preparation is used to relieve pain and reduce (high temperature), colds, influenza, and headaches, as it was produced according to the latest international pharmaceutical specifications.”“.
He pointed out, “The product was produced for the specialized marketing agency and will soon be marketed to the local market.”“.
What are the key benefits of Panadosam for consumers in Samarra during the colder months?
Interview: Resuming production of Panadosam – Insights from Muhammad Abdul Qadir Al-nuaimi
Time.news Editor (TNE): Thank you for joining us today, Mr.Al-Nuaimi. It’s exciting news that the General Company for the Manufacture of Pharmaceuticals and Medical Supplies in Samarra has resumed production of Panadosam. Can you tell us what led to the resumption after more than two years?
Muhammad Abdul Qadir al-Nuaimi (MNA): Thank you for having me. The production of Panadosam syrup was paused due to a meaningful shortage of some key raw materials that are essential for it’s production. Though, we have worked diligently to address these supply chain issues, and I’m pleased to announce that we have resumed manufacturing this critically important product in our program for November.
TNE: It’s great to hear that the production is back on track. For our readers,could you explain the importance of Panadosam in the local market and how it benefits consumers?
MNA: Certainly. Panadosam is a well-known product used primarily to relieve pain and reduce high temperatures associated with colds, influenza, and headaches.It adheres to the latest international pharmaceutical specifications, ensuring its efficacy and safety. With the current trends in health and wellness, having accessible and reliable medication like Panadosam is crucial for our community’s overall well-being.
TNE: With the rise of seasonal illnesses, how timely is the reintroduction of Panadosam?
MNA: The timing couldn’t be better. As we move into the colder months, the incidence of colds and flu typically increases. Panadosam will be a valuable option for families in managing these common ailments. its return to the market means that consumers will have a trusted product available when they need it the most.
TNE: You mentioned that the product will be marketed through a specialized agency. Can you elaborate on your marketing strategy and how you plan to ensure the local population is aware of Panadosam’s return?
MNA: We are collaborating closely with a specialized marketing agency to ensure that our outreach is both effective and informative. Our strategy includes educational materials that outline the benefits of Panadosam, where to purchase it, and dosage instructions. We aim to utilize multiple platforms — social media, local pharmacies, and community health programs — to ensure broad visibility and accessibility.
TNE: looking ahead, what implications does the resumption of Panadosam production have for the pharmaceutical industry in Samarra?
MNA: The resumption signifies a positive shift for the pharmaceutical industry in our region. It demonstrates our ability to overcome challenges and meet local health needs. Additionally, it highlights the importance of local manufacturing in reducing dependency on imports, which can be inconsistent and subject to international trends. This not only bolsters our economy but also reassures the community about the availability of essential medications.
TNE: Before we conclude, do you have any practical advice for consumers regarding the use of Panadosam or their approach to managing common ailments during the colder months?
MNA: absolutely. I advise consumers to read the instructions carefully when using Panadosam, ensuring they follow dosage recommendations.It’s also essential to maintain good hygiene practices, such as regular hand washing and proper nutrition, to bolster your immune system. If symptoms persist, seeking professional medical advice is always encouraged. our goal is to empower consumers with the knowledge to make informed health decisions.
TNE: Thank you for your insights,Mr. Al-Nuaimi. We look forward to seeing Panadosam back in the market and its positive impact on the community’s health.
MNA: Thank you for the opportunity to share this news. We’re excited about the future of Panadosam and our commitment to health protection in Samarra.